Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | May 24, 2023 01:31pm

Gainers

  • Minerva Surgical (NASDAQ:UTRS) shares rose 153.3% to $0.46 during Wednesday's regular session. Trading volume for this security as of 13:30 EST is 82.3 million, which is 14267.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $81.4 million.
  • Enveric Biosciences (NASDAQ:ENVB) stock rose 90.52% to $6.0. Trading volume for Enveric Biosciences's stock is 66.1 million as of 13:30 EST. This is 2999.9% of its average full-day volume over the last 100 days. The company's market cap stands at $12.4 million.
  • Zura Bio (NASDAQ:ZURA) shares rose 34.01% to $7.17. As of 13:30 EST, this security is trading at a volume of 13.1 million shares, making up 2966.4% of its average full-day volume over the last 100 days. The company's market cap stands at $228.0 million.
  • Apexigen (NASDAQ:APGN) stock moved upwards by 32.12% to $0.53. Trading volume for this security as of 13:30 EST is 8.7 million, which is 7955.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.0 million.
  • China Pharma Holding (AMEX:CPHI) stock rose 20.65% to $0.39. As of 13:30 EST, China Pharma Holding's stock is trading at a volume of 1.2 million, which is 333.4% of its average full-day volume over the last 100 days. The company's market cap stands at $3.7 million.
  • Biora Therapeutics (NASDAQ:BIOR) stock increased by 17.88% to $4.68. Trading volume for this security as of 13:30 EST is 244.3K, which is 175.5% of its average full-day volume over the last 100 days. The company's market cap stands at $55.5 million.

Losers

  • Biolase (NASDAQ:BIOL) shares fell 42.3% to $0.08 during Wednesday's regular session. As of 13:30 EST, Biolase's stock is trading at a volume of 33.3 million, which is 2090.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.5 million.
  • Ocugen (NASDAQ:OCGN) shares decreased by 36.06% to $0.46. As of 13:30 EST, this security is trading at a volume of 32.6 million shares, making up 494.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $104.0 million.
  • T2 Biosystems (NASDAQ:TTOO) stock declined by 30.65% to $0.12. Trading volume for T2 Biosystems's stock is 13.7 million as of 13:30 EST. This is 1681.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.4 million. The company's, Q1 earnings came out yesterday.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares declined by 28.38% to $0.14. Biodexa Pharmaceuticals's stock is trading at a volume of 4.3 million shares as of 13:30 EST. This is 106.4% of its average full-day volume over the last 100 days. The company's market cap stands at $2.6 million.
  • Oncorus (NASDAQ:ONCR) stock decreased by 24.8% to $0.18. As of 13:30 EST, Oncorus's stock is trading at a volume of 194.0K, which is 262.9% of its average full-day volume over the last 100 days. The company's market cap stands at $4.8 million. The company's, Q1 earnings came out 2 days ago.
  • CohBar (NASDAQ:CWBR) stock declined by 24.58% to $3.78. Trading volume for this security as of 13:30 EST is 1.4 million, which is 176.5% of its average full-day volume over the last 100 days. The company's market cap stands at $10.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: APGN BDRX BIOL BIOR CPHI CWBR ENVB OCGN ONCR TTOO UTRS ZURA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist